NEW YORK (GenomeWeb News) – ProteoNic and Oxford Expression Technologies today said they have expanded a prior agreement to grant OET a license to use ProteoNic's UNic translation enhancing elements.

OET will use the technology in its flashBAC system for third-party recombinant protein production services. As part of the deal, ProteoNic, based in Leiden, The Netherlands, will provide technical support. Financial terms include upfront payments and royalty payments of an undisclosed amount.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.

Oct
10
Sponsored by
PerkinElmer

This online, interactive seminar will answer researchers’ most pressing questions about how to gain outstanding research results from proteomic studies.